The EuPAT8 will focus on PAT integration into pharmaceutical manufacturing, the biopharmaceutics risk assessment roadmap (BioRAM) for the integration of preclinical, clinical and pharmaceutical development including QbD for better products and QbD considerations for emerging therapies (biosimilars and nanomedicines). Technical, practical and regulatory challenges in each of these focus areas will be explored and debated in detail. The conference builds on the success of the EuPAT series established in 2006 and will be organised by EUFEPS and its QbD and PAT Sciences Network, cosponsored by the University College Cork (UCC), the Irish based Synthesis and Solid State Pharmaceutical Centre (SSPC) and Pharmaceutical Manufacturing Technology Centre (PMTC). It is organised back-to-back with a training day centred on “Considerations for implementing a PAT technology into a new or existing pharma process”, which will be organised, at the School of Pharmacy, UCC. The attendees of EuPAT8 are welcome to register for the pre-conference day and vice versa.
Session Topics at EuPAT 8 are:
PAT implementation in manufacturing I (small molecule)
PAT implementation in manufacturing II (biologics)
Biopharmaceutics risk assessment roadmap (BioRAM)
Biosimilars and Nanomedicines
For the Preliminary Programme see the website.
Session Topics at EuPAT 8 are:
PAT implementation in manufacturing I (small molecule)
PAT implementation in manufacturing II (biologics)
Biopharmaceutics risk assessment roadmap (BioRAM)
Biosimilars and Nanomedicines
For the Preliminary Programme see the website.
